帶狀疱疹或單純性疱疹侵犯薦椎s2皮節课件

Herpes zoster and Postherpetic neuralgia 台北市立聯合醫院皮膚科 林瑞宜 1 學經歷 1972年 國立台灣大學醫學部醫科 畢業 1973年 國立台灣大學醫科附設醫院皮膚 科住院醫師 1977年 台灣台北市立和平醫院皮膚科主任 1980年 國立台灣大學醫科附設醫院皮膚科兼任講師(現在) 1980-2007年: 台灣皮膚科醫學會理事(曾任常務理事，理事長) 1984年 美國哈佛大學麻省總醫院皮膚病理研究所 (1984/071985/06) 1993年 台灣台北市立和平醫院皮膚科主治醫師 1995年 台灣台北市立性病防治所所長 1998年 台灣台北市立和平醫院院長 2001年 台灣台北市立和平醫院顧問醫師兼皮膚科主治醫師, 2005年 台灣台北聯合醫院皮暨和平院區皮膚科主任 (現在) 2008年 衛生署藥害審議委員會委員 2 Epidemiological Features and Costs of Herpes Zoster in Taiwan: A National Study 2000 to 2006 Acta Derm Venereol 2009; 89: 612616 Overall, 34,280 patients were diagnosed with zoster (incidence 4.89/1000 person-years) A total of 4543 patients (13.3%) had persistent neuralgia one month after the start of the zoster rash (incidence 0.64/1000 person-years), 2944 patients (8.6%) developed postherpetic neuralgia 3 months after the start of the zoster rash (incidence 0.42/1000 person-years). overall hospitalization rate for zoster was 16.1 cases per 100,000 person-years. The cost for each home care case and per hospitalized case were approximately $NT1655 and $NT38,051, respectively 3 Epidemiological Features and Costs of Herpes Zoster in Taiwan: A National Study 2000 to 2006 Acta Derm Venereol 2009; 89: 612616 4 Epidemiological Features and Costs of Herpes Zoster in Taiwan: A National Study 2000 to 2006 Acta Derm Venereol 2009; 89: 612616 5 Epidemiological Features and Costs of Herpes Zoster in Taiwan: A National Study 2000 to 2006 Acta Derm Venereol 2009; 89: 612616 6 Epidemiological Features and Costs of Herpes Zoster in Taiwan: A National Study 2000 to 2006 Acta Derm Venereol 2009; 89: 612616 7 Epidemiological Features and Costs of Herpes Zoster in Taiwan: A National Study 2000 to 2006 Acta Derm Venereol 2009; 89: 612616 8 goals of therapy for herpes zoster J Am Acad Dermatol 2007;57:S136-42 The goals of therapy for herpes zoster are to accelerate healing, limit the severity and duration of pain, reduce complications, which include, in addition to postherpetic neuralgia, encephalitis, myelitis, cranial and peripheral palsies, a syndrome of delayed contralateral hemiparesis, and acute retinal necrosis. 9 Management and prevention of herpes zoster: a Canadian perspective. Varicella-zoster virus reactivation leads to herpes zoster the main complication of which is postherpetic neuralgia (PHN). Rapid antiviral therapy initiated within 72 within 72 h h of rashof rash onset has been shown to accelerate rash healing, reduce the duration of acute pain and, to some extent, attenuate the development and duration of PHN. Can J infect dis Med Microbiol 2010;21(1):45-52. 10 Pathogenesis and diagnosis Varicella-zoster virus (VZV), a member of the Herpesviridae family Following an incubation period of 14 to 21 days, the primary infection is varicella (chickenpox). The virus then migrates via retrograde axonal transport to sensory ganglia, where it establishes lifelong latency. VZV reactivations can be asymptomatic or symptomatic leading to the development of zoster, which typically occurs many decades after primary infection. 11 Clinical manifestation of Herpes zoster A typical zoster rash in an immunocompetent individual involves one or two adjacent dermatomes, and usually lasts seven to 10 days. Thoracic dermatomes up to 50% of cases, Ophthalmic areas in 1% to 10% About 75% patients report having prodromal pain (zoster sine herpete) can precede the rash by days to weeks 12 Clinical manifestation of Herpes zoster Because zoster rash is so typical, diagnosis can be made clinically in most instances. In very early stage, red edematous plaque may be confused with cellulitis or contact dermatitis. While few papular lesions only, differentiate from herpes simplex virus (HSV) or conditions such as impetigo, folliculitis, insect bites etc The rash may be atypical dissemination or chronicity in immunocompromised patients. 13 Laboratory diagnostic test of Herpes zoster Swabs and cell scrapings from the base for Direct fluorescent antibody staining (DIF), 90% positive in vesicular stage (DDx VZV/HSV) Cell culture : 60% to 75%, need one week Polymerase chain reaction (PCR) the mostsensitive diagnostic method to distinguish wild-type VZV from the vaccine Oka strain Tzanck cytology : ballooning cells and multinucleated giant cells Cytopathic viral infection 14 Herpes zoster 15 Complication of Herpes zoster Pain is the most frequent complication. Acute pain occurring within 30 days after rash onset, subacute pain (between 30 days and 90 to 120 days) postherpetic neuralgia (PHN), significant pain and persists longer than 90 to 120 days after rash onset. Keratitis, 2/3 in Hepes zoster ophthalmicus neurological complications Ramsay Hunt syndrome: HZ of the facial nerve, with vesicles on the ear, palate or tongue leading to facial paresis, hearing loss and vertigo. Others: myelitis, aseptic meningitis, Bells palsy, etc 16 Complication of Herpes zoster 17 Complication of Herpes zoster Visceral dissemination: fatality rate of 5% to 15%,even with antiviral therapy cellular immunodeficiency : HIV, hematological malignancies, solid tumours, and following stem cell or organ transplantation, 皮蛇繞身體一圈後，病人可能沒救了? Soft tissue infection, ? After NSAID 18 Postherpetic Neuralgia (PNH) The risk of PHN, given an episode of zoster, increases with age. 10% of patients with zoster in one-third of zoster patients 60 y/o incidence of 14 cases per 10,000 person-years In addition to advancing age, the severity of acute pain and rash, prodromal pain, ophthalmic location and possibly female sex are also risk factors for PHN 19 Antiviral Treatment for Herpes zoster The main objectives of antiviral treatment are: to reduce viral replication, To reduce duration of rash and acute pain to prevent complications seen mostly in immunocompromised patients. early antiviral therapy may also attenuate development of PHN. 健保規定為: 發生皮疹的72hours內 一般人治療為五天 Famciclovir 250mg TID x 5 20 10.7.1.1. 全身性抗疱疹病毒劑 Acyclovir：(98/11/1、100/7/1) 使用本類製劑應以下列條件為限： 疱疹性腦炎。 帶狀疱疹或單純性疱疹侵犯三叉神經第一分枝VI皮節，可能危及眼角 膜者。 帶狀疱疹或單純性疱疹侵犯薦椎S2皮節，將影響排泄功能者。 免疫機能不全、癌症、器官移植等病患之感染帶狀疱疹或單純性疱疹 者。 新生兒或免疫機能不全患者的水痘感染。 罹患水痘，合併高燒 (口溫38以上) 及肺炎 (需光顯示) 或腦膜 炎，並需住院者（85/1/1）。 帶狀疱疹或單純性疱疹所引起之角膜炎或角膜潰瘍者。 急性視網膜壞死症 (acute retina necrosis)。 帶狀疱疹發疹三日內且感染部位在頭頸部、生殖器周圍之病人，可給 予五日內之口服或外用藥品(86/1/1、87/4/1)。 骨髓移植術後病患得依下列規定預防性使用acyclovir：（87/11/1） 限接受異體骨髓移植病患。 接受高劑量化療或全身放射治療 (TBI) 前一天至移植術後 第卅天為止。 其中與應優先考慮注射劑型的acyclovir。疱疹性腦炎得使用14至21天。（ 95/6/1、100/7/1）21 10.7.1.1. 全身性抗疱疹病毒劑 2.Famciclovir；valaciclovir：(100/7/1) 使用本類製劑應以下列條件為限： 帶狀疱疹或單純性疱疹侵犯三叉神經第一分枝VI皮節，可能危及眼角 膜者。 帶狀疱疹或單純性疱疹侵犯薦椎S2皮節，將影響排泄功能者。 免疫機能不全、癌症、器官移植等病患之感染帶狀疱疹或單純性疱疹 者。 帶狀疱疹或單純性疱疹所引起之角膜炎或角膜潰瘍者。 急性視網膜壞死症 (acute retina necrosis)。 帶狀疱疹發疹3日內且感染部位在頭頸部、生殖器周圍之病人，可給 予5日內之口服或外用藥品。 骨髓移植術後病患得依下列規定預防性使用acyclovir： A.限接受異體骨髓移植病患。 B.接受高劑量化療或全身放射治療(TBI)前一天至移植術後第30天為 止。 3. Acyclovir、Famciclovir及valaciclovirt除上述特別規定外，使用 療程原則以10天為限，口服、注射劑及外用藥膏擇一使用，不得合併 使用。（95/6/1、100/7/1） 22 Antiviral Treatment for Herpes zoster In Taiwan, the usual dosage for Famciclovir is 250mg TID 23 Usage of Famciclovir for Herpes zoster Equal efficacy is noted in RCT 559 immunocompetent adults treated for 7 days (initiated within 72 hours of onset of zoster skin lesions) famciclovir (750 mg QD, 500 mg BID, or 250 mg TID) acyclovir (800mg x5/day ). J Clin Virol 2004;29:248-53 Famciclovir, like acyclovir, has also been shown to reduce the duration of postherpetic neuralgia by a median of 2 months. Ann Intern Med 1995;123:89-96 24 Rash severity in herpes zoster: Correlates and relationship to postherpetic neuralgia J Am Acad Dermatol 2002;46:834-9 25 BRITISH MEDICAL JOURNAL 293: 1529, 1986 26 Frequently descriptions in Textbook or Review Articles Antiviral drugs have been consistently found to effectively reduce the severity and duration of herpes zoster, and are safe and well tolerated with minimal adverse effects. They do not, however, reliably prevent the development of postherpetic neuralgia. 27 ANTIMICROB AGENTS CHEMOTHERA 39:15461553, 1995 28 In Canada Oral therapy with one of the three antivirals is recommended as first-line treatment for all immunocompetent patients who consult rapidly (preferably within 72 h of rash onset) who fulfill any of the following criteria: 50 years of age or older; moderate or severe acute pain; moderate or severe rash; Nontruncal involvement 29 Late antiviral treatment Of note, the 72 h inclusion criterion has been arbitrarily chosen in randomized clinical trials and may not be optimal in clinical practice. The presence of new vesicles, which reflect active viral replication, may be an alternative way to select patients for antiviral treatment. Ophthalmic zoster should be treated more aggressively, including referral for eye assessment and starting of antiviral therapy even beyond the 72 h period. 30 Usage of corticosteroids in HZ Although showing some benefits in acute zoster pain, corticosteroids do not provide added value over acyclovir in reducing PHN, and are thus not recommended in the initial management of HZ . 31 Acute pain associated with herpes zoster Defined as pain before and during blister eruption. Prodromal pain can consist of various symptoms, e.g. itching, burning, tingling, stubbing, tenderness superficial and deep pain. Usually moderate-to-severe acute pain caused by acute neuritis, can last for nearly a month. Pathogenesis of acute pain an abnormal discharge in the dorsal horn, by the inflammation of the dorsal root ganglion, by the extent of the neuritis and the dermal vasculitis. 32 Use of NSAID in VZV infection 33 NSAID may induce more infection 34 Use of NSAID in VZV infection RESULTS In patients with varicella, there were 386 cases of severe skin or soft tissue complications (rate 2.8 per 1000) during the 2month follow-up period (mean age 10.7 years). The rate of complications associated with exposure to NSAIDs was increased (rate ratio 4.9; 95% CI 2.1, 11.4). In patients with zoster disease, there were 681 cases of severe skin or soft tissue complications (rate 6.3 per 1000) during the 2month follow-up (mean age 60.9 years). The rate ratio of complications associated with exposure to NSAIDs was 1.6 (95% CI 1.1, 2.4). In both conditions, there was no increased risk of complication associated with a current exposure to paracetamol. CONCLUSIONS The